Jeong Eun Lee

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 29

Top Topics

Intensive Care Unit

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Thoracic cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jeong Eun Lee, Jin Hyun Nam, Sun Hong Kwon, Bo Kyung Kim, Seung Min Ha
Real-world evidence of brigatinib as second-line treatment after crizotinib for ALK+ non-small cell lung cancer using South Korean claims data (K-AREAL). Cancer medicine 13 (14) (2024)
Da Som Jeon, Cheol-Kyu Park, Seung Joon Kim, Chan Kwon Park, Yoon Soo Chang, Chi Young Jung, Sung-Yong Lee, Shin-Yup Lee, Jeong-Seon Ryu, Jeong Eun Lee, Kye Young Lee, Tae Won Jang, Seung Hun Jang, Seong Hoon Yoon, Sang Hoon Lee, Chang-Min Choi, Hyeong Ryul Kim, Yeon Joo Kim
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic cancer 15 (6) (2024)
Jeong Eun Lee, Jin Hyun Nam, Sun Hong Kwon, Bo Kyung Kim, Seung Min Ha
Real-world evidence of brigatinib as second-line treatment after crizotinib for ALK+ non-small cell lung cancer using South Korean claims data (K-AREAL). Cancer medicine 13 (14) (2024)
Yeon Hee Park, Dahye Lee, Jeong Eun Lee, Hee Sun Park, Sung Soo Jung, Dongil Park, Da Hyun Kang, Song-I Lee, Seong-Dae Woo, Chaeuk Chung
The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma. Cancers 16 (3) (2024)
Da Som Jeon, Cheol-Kyu Park, Seung Joon Kim, Chan Kwon Park, Yoon Soo Chang, Chi Young Jung, Sung-Yong Lee, Shin-Yup Lee, Jeong-Seon Ryu, Jeong Eun Lee, Kye Young Lee, Tae Won Jang, Seung Hun Jang, Seong Hoon Yoon, Sang Hoon Lee, Chang-Min Choi, Hyeong Ryul Kim, Yeon Joo Kim
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic cancer 15 (6) (2024)
Da Som Jeon, Cheol-Kyu Park, Seung Joon Kim, Chan Kwon Park, Yoon Soo Chang, Chi Young Jung, Sung-Yong Lee, Shin-Yup Lee, Jeong-Seon Ryu, Jeong Eun Lee, Kye Young Lee, Tae Won Jang, Seung Hun Jang, Seong Hoon Yoon, Sang Hoon Lee, Chang-Min Choi, Hyeong Ryul Kim, Yeon Joo Kim
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic cancer 15 (6) (2024)
Da Som Jeon, Cheol-Kyu Park, Seung Joon Kim, Chan Kwon Park, Yoon Soo Chang, Chi Young Jung, Sung-Yong Lee, Shin-Yup Lee, Jeong-Seon Ryu, Jeong Eun Lee, Kye Young Lee, Tae Won Jang, Seung Hun Jang, Seong Hoon Yoon, Sang Hoon Lee, Chang-Min Choi, Hyeong Ryul Kim, Yeon Joo Kim
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic cancer (2024)
Hyeon Hwa Kim, Jae Cheol Lee, In Jae Oh, Eun Young Kim, Seong Hoon Yoon, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Chan Kwon Park, Kye Young Lee, Sung-Yong Lee, Seung Joon Kim, Jun Hyeok Lim, Chang-Min Choi
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer. Cancers 16 (3) (2024)
Jeong Eun Lee, Jin Hyun Nam, Sun Hong Kwon, Bo Kyung Kim, Seung Min Ha
Real-world evidence of brigatinib as second-line treatment after crizotinib for ALK+ non-small cell lung cancer using South Korean claims data (K-AREAL). Cancer medicine 13 (14) (2024)
Yeon Hee Park, Dahye Lee, Jeong Eun Lee, Hee Sun Park, Sung Soo Jung, Dongil Park, Da Hyun Kang, Song-I Lee, Seong-Dae Woo, Chaeuk Chung
The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma. Cancers 16 (3) (2024)
Hyeon Hwa Kim, Jae Cheol Lee, In Jae Oh, Eun Young Kim, Seong Hoon Yoon, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Chan Kwon Park, Kye Young Lee, Sung-Yong Lee, Seung Joon Kim, Jun Hyeok Lim, Chang-Min Choi
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer. Cancers 16 (3) (2024)
Da Som Jeon, Cheol-Kyu Park, Seung Joon Kim, Chan Kwon Park, Yoon Soo Chang, Chi Young Jung, Sung-Yong Lee, Shin-Yup Lee, Jeong-Seon Ryu, Jeong Eun Lee, Kye Young Lee, Tae Won Jang, Seung Hun Jang, Seong Hoon Yoon, Sang Hoon Lee, Chang-Min Choi, Hyeong Ryul Kim, Yeon Joo Kim
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic cancer 15 (6) (2024)
Song-I Lee, Chaeuk Chung, Dong Il Park, Da Hyun Kang, Ye-Rin Ju, Jeong Eun Lee
The Influence of Sex on Characteristics and Outcomes of Coronavirus-19 Patients: A Retrospective Cohort Study. Journal of clinical medicine 12 (3) (2023)
Song-I Lee, Chaeuk Chung, Dong Il Park, Da Hyun Kang, Ye-Rin Ju, Jeong Eun Lee
The Influence of Sex on Characteristics and Outcomes of Coronavirus-19 Patients: A Retrospective Cohort Study. Journal of clinical medicine 12 (3) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Song-I Lee, Chaeuk Chung, Dong Il Park, Da Hyun Kang, Ye-Rin Ju, Jeong Eun Lee
The Influence of Sex on Characteristics and Outcomes of Coronavirus-19 Patients: A Retrospective Cohort Study. Journal of clinical medicine 12 (3) (2023)
Dong Il Park, Dahye Lee, Yoonjoo Kim, Yeonhee Park, Yeon-Jae Lee, Jeong Eun Lee, Min-Kyung Yeo, Min-Woong Kang, Yooyoung Chong, Sung Joon Han, Jinwook Choi, Jong-Eun Park, Yongjun Koh, Jaehyeok Lee, Yong Keun Park, Ryul Kim, Jeong Seok Lee, Jimin Choi, Sang-Hyun Lee, Bosung Ku, Da Hyun Kang, Chaeuk Chung
Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids. Cells 12 (14) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Green Hong, Chaeuk Chung, Dong Il Park, Song-I Lee, Jeong Eun Lee, Da Hyun Kang
Spontaneous regression of recurrent pulmonary large cell neuroendocrine carcinoma with alteration of PD-L1 expression after surgical resection: A case report. Thoracic cancer (2023)
Green Hong, Pureum Sun, Chaeuk Chung, Dong Il Park, Song I Lee, Nayoung Kim, Seong Eun Lee, Jeong Eun Lee, Yea Eun Kang, Da Hyun Kang
Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer. Journal of cancer research and clinical oncology (2022)
Song-I Lee, Jeong Suk Koh, Yoon Joo Kim, Da Hyun Kang, Jeong Eun Lee
Characteristics and outcomes of patients screened by rapid response team who transferred to the intensive care unit. BMC emergency medicine 22 (1) (2022)
Da Hyun Kang, Seong-Woo Choi, Pureum Sun, Chaeuk Chung, Dong Il Park, Song I Lee, Jeong Suk Koh, Yoonjoo Kim, Jeong Eun Lee
The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer. Thoracic cancer 13 (16) (2022)
Yunha Nam, Ho Cheol Kim, Young-Chul Kim, Seung Hun Jang, Kye Young Lee, Shin-Yup Lee, Sang Hoon Lee, Sung Yong Lee, Seong Hoon Yoon, Jeong-Seon Ryu, Tae Won Jang, Yoon Soo Chang, Seung Joon Kim, Chan Kwon Park, Jeong Eun Lee, Chi Young Jung, Chang-Min Choi
Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting. Thoracic cancer 12 (6) (2021)
Hee Sun Park, Da-Hye Lee, Da Hyun Kang, Min-Kyung Yeo, Goeun Bae, Dahye Lee, Geon Yoo, Ju-Ock Kim, Eunyoung Moon, Yang Hoon Huh, Sang-Hee Lee, Eun-Kyeong Jo, Sang Yeon Cho, Jeong Eun Lee, Chaeuk Chung
Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma. Cancer medicine 10 (4) (2021)
Da Hyun Kang, Chaeuk Chung, Pureum Sun, Da Hye Lee, Song I Lee, Dong Il Park, Jeong Suk Koh, Yoonjoo Kim, Hyon Seung Yi, Jeong Eun Lee
Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors. Cancer immunology, immunotherapy : CII (2021)
Da Hyun Kang, Cheol-Kyu Park, Chaeuk Chung, In Jae Oh, Young-Chul Kim, Dong Il Park, Jinhyun Kim, Gye Cheol Kwon, In Sun Kwon, Pureum Sun, Eui-Cheol Shin, Jeong Eun Lee
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors. Immune network 20 (3) (2020)
Yeon Hee Park, Chae Uk Chung, Bo Mi Park, Myoung Rin Park, Dong Il Park, Jae Young Moon, Hee Sun Park, Jin Hwan Kim, Sung Soo Jung, Ju Ock Kim, Sun Young Kim, Jeong Eun Lee
Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs. Canadian respiratory journal 2016 (2016)